Időskori makuladegeneráció: vizsgálatok itt: Kína
37 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Shanghai
- Életkor
- 50 év and over
- People
- 272 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00 - 1. fázisTaking peopleSafety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
- Where
- Chengdu
- Életkor
- 50 év and over
- People
- 18
- Run by
- InnoVec Biotherapeutics Inc.
See details and how to joinNCT06737354 - 2/3. fázisTaking peopleA Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Where
- Beijing, Chengdu, Shanghai
- Életkor
- 60 év and over
- People
- 274 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00 - 1/2. fázisTaking peopleSafety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)
- Where
- Beijing
- Életkor
- 50 év to 85 év
- People
- 198
- Run by
- Fujian Haixi Pharmaceuticals Co., Ltd.
See details and how to joinNCT07185841 - 1/2. fázisTaking peopleStudy in Human iPSCs-derived RPE Cells Transplantation for Advanced (Late-stage) AMD
- Where
- Nanjing
- Életkor
- 50 év to 85 év
- People
- 12
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07418177 - 1. fázisNot yet taking people in KínaA Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion
- Where
- Shanghai
- Életkor
- 18 év to 85 év
- People
- 60
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT07817615 - No phaseTaking peopleA Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
- Where
- Beijing, Hangzhou, Hefei, Shanghai, Wenzhou
- Életkor
- 50 év and over
- People
- 83 worldwide
- Run by
- Skyline Therapeutics
See details and how to joinNCT06346600 - 1/2. fázisTaking peoplePhase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
- Where
- Beijing, Hangzhou, Hefei, Wenzhou
- Életkor
- 50 év and over
- People
- 68 worldwide
- Run by
- Skyline Therapeutics (US) Inc.
See details and how to joinNCT05986864 - 2. fázisTaking peoplePhase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
- Where
- Beijing, Chengdu, Chongqing, Harbin, Jilin City, Kunming, Nanjing, Shanghai, Shantou, Taiyuan, Tianjin, Wuhan, Zhejiang, Zhengzhou
- Életkor
- 50 év to 85 év
- People
- 50
- Run by
- West China Hospital
See details and how to joinNCT07776522 - 3. fázisTaking peopleEfficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanjing, Qingdao, Shanghai, Shantou, Shenyang, Taiyuan, Tianjin, Wenzhou, Wuhan, Xi’an, Xingtai, Xuzhou, Zhongshan
- Életkor
- 50 év to 80 év
- People
- 388
- Run by
- Innostellar Biotherapeutics Co.,Ltd
See details and how to joinNCT07317934 - No phaseTaking peopleReal-world Study of Aflibercept 8 mg in nAMD
- Where
- Beijing, Chengdu, Dalian, Fuzhou, Harbin, Hohhot, Jinan, Nanyang, Ningbo, Qingdao, Shanghai, Shenyang, Shenzhen, Tianjin, Wenzhou, Wuhan, Xi’an, Zunyi
- Életkor
- 50 év and over
- People
- 300
- Run by
- Peking University People's Hospital
See details and how to joinNCT07640997 - No phaseNot yet taking people in KínaAI vs. Physician for Anti-VEGF Decision-Making: An RCT
- Where
- Shanghai
- Életkor
- 50 év to 85 év
- People
- 200
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07328776 - No phaseNot yet taking people in KínaProspective, Single Arm, Observational Study of Faricimab in the Treatment of Neovascular Age-related Macular Degeneration (nAMD)
- Where
- Guangzhou
- Életkor
- 50 év and over
- People
- 50
- Run by
- Sun Yat-sen University
See details and how to joinNCT07581782 - No phaseNot yet taking people in KínaPterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy
- Where
- Shanghai
- Életkor
- 50 év to 80 év
- People
- 62
- Run by
- Shanghai Institute of Acupuncture, Moxibustion and Meridian
See details and how to joinNCT07570355 - Korai 1. fázisTaking peopleSafety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
- Where
- Shanghai
- Életkor
- 50 év and over
- People
- 10
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07053358 - No phaseNot yet taking people in KínaRepeated Low-Level Red-Light Therapy in Dry Age-Related Macular Degeneration
- Where
- Hong Kong
- Életkor
- 50 év and over
- People
- 94
- Run by
- The Hong Kong Polytechnic University
See details and how to joinNCT07409389 - 1. fázisNot yet taking people in KínaTo Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
- Where
- Beijing, Guiyang, Hangzhou, Nanchang, Zhengzhou
- Életkor
- 50 év to 80 év
- People
- 48
- Run by
- Shenzhen Kexing Pharmaceutical Co., Ltd.
See details and how to joinNCT07406438 - 4. fázisNot yet taking people in KínaA Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)
- Where
- Beijing, Foshan, Hangzhou, Harbin, Jiaxing, Jilin City, Jinan, Kunming, Nanchang, Nanjing, Shanghai, Taiyuan, Tianjin, Weifang, Wuhan, Xi'an, Xianyang, Zhengzhou
- Életkor
- 50 év and over
- People
- 174
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07365371 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
- Where
- Shanghai
- Életkor
- 50 év and over
- People
- 800
- Run by
- Innovent Biologics Technology Limited (Shanghai R&D Center)
See details and how to joinNCT07275840 - No phaseTaking peopleEffect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
- Where
- Shanghai
- Életkor
- 50 év to 85 év
- People
- 24
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT05465252 - No phaseTaking peopleNatural History Study of Inherited Retinal Diseases
- Where
- Wuhan
- People
- 200
- Run by
- Augelux Therapeutics
See details and how to joinNCT07085533 - 3. fázisTaking peopleQA108 Phase III Study in Subjects With Intermediate AMD
- Where
- Beijing
- Életkor
- 45 év to 85 év
- People
- 400
- Run by
- Smilebiotek Zhuhai Limited
See details and how to joinNCT07189169 - 1/2. fázisTaking peopleMulticenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMD
- Where
- Tianjing
- Életkor
- 45 év to 80 év
- People
- 82
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT06672536 - Korai 1. fázisTaking peopleAn Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease
- Where
- Shanghai
- Életkor
- 6 év to 17 év
- People
- 6
- Run by
- HuidaGene Therapeutics Co., Ltd.
See details and how to joinNCT07063251 - No phaseTaking peopleA Long-term Follow up Study of EXG102-031 in Participants With wAMD
- Where
- Beijing
- Életkor
- 50 év and over
- People
- 42
- Run by
- Guangzhou Jiayin Biotech Ltd
See details and how to joinNCT06859515